HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum bactericidal activity against Neisseria meningitidis in patients with C3 nephritic factors is dependent on IgG allotypes.

Abstract
The main mechanisms of immune defense against Neisseria meningitidis are serum bactericidal activity (SBA) and opsonophagocytosis. Many complement deficiencies, among them acquired partial C3 deficiency due to stabilizing autoantibodies against the alternative pathway C3 convertase (C3 nephritic factors, C3 NeF); increase the risk of meningococcal infection. SBA against meningococci in patients with C3 NeF was determined along with allelic variants (GM alleles) of the immunoglobulin constant heavy G chain (IGHG) genes. In patients with C3 NeF and in control children, individuals homozygous for G1M*f and G3M*b showed higher SBA against meningococci than heterozygous individuals. Partial complement deficiency in early childhood might explain the influence of GM variants on SBA in control children. These novel findings imply that the IGHG genotype is important in defense against meningococci in individuals with low complement function and possibly in combination with other immunodeficiencies.
AuthorsL Skattum, B Gullstrand, E Holmström, V-A Oxelius, L Truedsson
JournalClinical immunology (Orlando, Fla.) (Clin Immunol) Vol. 129 Issue 1 Pg. 123-31 (Oct 2008) ISSN: 1521-7035 [Electronic] United States
PMID18667363 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Complement C3 Nephritic Factor
  • Immunoglobulin G
  • Immunoglobulin Gm Allotypes
  • Complement System Proteins
Topics
  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Blood Bactericidal Activity
  • Child
  • Child, Preschool
  • Complement C3 Nephritic Factor (analysis, genetics, immunology)
  • Complement System Proteins (analysis, deficiency)
  • Genotype
  • Humans
  • Immunoglobulin G (blood, genetics, immunology)
  • Immunoglobulin Gm Allotypes (genetics)
  • Middle Aged
  • Neisseria meningitidis (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: